Bearish flow noted in Novavax with 16,675 puts trading, or 2x expected. Most active are 1/13 weekly 9.5 puts and 1/13 weekly 8.5 puts, with total volume in those strikes near 8,800 contracts. The Put/Call Ratio is 1.72, while ATM IV is up over 3 points on the day. Earnings are expected on February 27th.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on NVAX:
- Novavax announces initiation of Phase2 trial for CIC, influenza vaccines
- Researchers Question the Effectiveness of Novavax’s (NYSE:NVAX) COVID Shots
- Novavax call volume above normal and directionally bullish
- Novavax to initiate phase 2 influenza CIC trial by end 2022
- Largest borrow rate increases among liquid names